Skip to main content
. 2016 Apr 29;7(24):35894–35916. doi: 10.18632/oncotarget.9116

Table 4. Apoptosis rate (%) of the CD90+ LCSCs.

Group Apoptosis rate (x¯±S,n=3)
Control 4.1±1.1
TMs alone 4.5±2.4
Anti-CD90 mAb 5.2±1.4
Anti-CD20 mAb 3.8±2.9
CD90@TMs alone 5.7±1.6
TMs+AMF 19.9±6.4**
CD90@TMs+AMF 66.3±6.9**

Notes: Data are presented as means ± standard deviation. Each experiment was repeated at least three times.

**

Comparisons between the experimental groups and the control group, P < 0.05.